The Onychomycosis Global Market Report 2023, provides comprehensive information on the onychomycosis market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Onychomycosis Market’s Growth:
https://www.thebusinessresearchcompany.com/report/onychomycosis-global-market-report
The global onychomycosis market is expected to grow from $3.20 billion in 2022 to $3.40 billion in 2023 at a compound annual growth rate (CAGR) of 6.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The onychomycosis market is expected to reach $4.19. billion in 2027 at a CAGR of 5.4%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=12197&type=smp
Product innovation is a key trend gaining popularity in the onychomycosis market. Major companies operating in the onychomycosis market are developing innovative products to sustain their position in the market. For instance, in December 2021, Bausch Health Companies Inc., a Canada-based pharmaceutical company, launched a Julia (aliconazole) topical solution for the treatment of onychomycosis. Julia is approved by the American Podiatric Medical Association (APMA), a US-based professional medical organization. Products that support good foot health and are of significant benefit when used in a consistently applied program of daily foot care and frequent professional treatment are given the APMA Seal of Approval
The onychomycosis market is segmented:
1) By Type: Distal Subungual Onychomycosis (DSO), White Superficial Onychomycosis (WSO), Proximal Subungual Onychomycosis (PSO), Candida Onychomycosis, Other Types
2) By Treatment: Drug Treatment, Topical Therapy, Other Treatments
3) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Other Distribution Channels
North America was the largest region in the onychomycosis market in 2022.
The table of contents in TBRC’s onychomycosis market report includes:
1. Executive Summary
2. Onychomycosis Market Characteristics
3. Onychomycosis Market Trends And Strategies
4. Onychomycosis Market – Macro Economic Scenario
5. Onychomycosis Market Segmentation
.
.
.
26. South America Onychomycosis Market
27. Brazil Onychomycosis Market
28. Middle East Onychomycosis Market
29. Africa Onychomycosis Market
30. Onychomycosis Market Competitive Landscape And Company Profiles
Top Major Players:
- Pfizer Inc
- Johnson & Johnson Services Inc
- Merck & Co. Inc
- Bayer AG
- Novartis AG
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
